
Andrew L. Pecora, M.D. receives the 2018
Chief innovations officer at Hackensack Meridian Health Recognized for Vision, Innovation and Leadership.
February 2, 2018 (Hackensack, N.J.) -- Andrew L. Pecora, M.D., FACP, CPE, president, Physician Enterprise and chief innovations officer at Hackensack Meridian Health, was honored with the 2018 Dr. Sol J. Barer Award for Vision, Innovation and Leadership at the Gateway Gala, BioNJ’s 25th Annual dinner meeting, networking event and innovation celebration on Feb. 1 at the Hilton, East Brunswick, NJ.
“Andrew Pecora is a remarkable physician, researcher and innovator,” said Robert C. Garrett, co-CEO of Hackensack Meridian Health. “This recognition is so well deserved because of Dr. Pecora’s outstanding leadership which has resulted in tangible improvements in patient outcomes and health care delivery. I am honored to call him a colleague and friend."
A certified hematologist and oncologist, Dr. Pecora is recognized internationally as one of the world’s foremost experts in blood and marrow stem cell transplantation, cellular medicine and immunology research. In 1989, he spearheaded the development of the John Theurer Cancer Center’s Adult Blood and Marrow Stem Cell Transplantation Program and is responsible for many advancements used in stem cell transplantation today.
Dr. Pecora’s current research involves developing vaccines and other cellular medicine techniques that boost the capabilities of a patient’s own immune system to fight cancer and targeted therapies that destroy cancer cells. His research has been published extensively in prestigious medical journals and he is a frequently requested lecturer at conferences all over the world.
A serial entrepreneur, Dr. Pecora has created multiple companies in biotechnology healthcare and information technology, and holds over 50 national and international patents covering the composition and use of bone marrow derived cells for treating cardiovascular disease and for applications in precision analytics. He is the founder and first president of Regional Cancer Care Associates and professor of oncology and medicine, Georgetown University.
In 2017, the Hackensack Meridian Health Board of Trustees approved a $25 million capital fund to create incubator space, among other initiatives, to promote innovation, which has drawn interests from venture capitalists and life science companies.
“The work that Dr. Pecora is doing - for patients, for medicine, for science, for New Jersey - defines vision, innovation and leadership,” says BioNJ President and CEO Debbie Hart. “He is deserving of this award for what he has done and what he is sure to do in the future. Through his work, Dr. Pecora is disrupting the practice of medicine, disrupting innovation, disrupting our ecosystem and disrupting the future of health care. BioNJ is thrilled to honor this amazing man in this way and anxious to see his future unfold.”
About the Dr. Sol J. Barer Award
About BioNJ’s Annual Meeting
About BioNJ
ABOUT JOHN THEURER CANCER CENTER AT HACKENSACK UNIVERSITY MEDICAL CENTER
About Hackensack Meridian Health Hackensack University Medical Center
ABOUT HACKENSACK MERIDIAN HEALTH
“It’s an honor to receive this acknowledgement, and I am deeply thankful for my professional colleagues at the John Theurer Cancer Center and the administration at Hackensack Meridian Health, which have supported an environment that drives innovation,” said Dr. Pecora. “This recognition is bestowed upon an entire medical community working together to develop new approaches that will improve the lives of people in New Jersey and influence the nation and the world.”The Dr. Sol J. Barer Award for Vision, Innovation, and Leadership was established by the BioNJ Board of Trustees in March 2008 in an effort to recognize the outstanding research and business leaders who have made and continue to make significant contributions to the growth of the biosciences in New Jersey and around the world. The honoree is voted on by the BioNJ Board of Trustees from a recommendation based on nominations received by the Nominating Committee. The award is named for Sol J. Barer, Ph.D., who founded the biotechnology group at Celanese that was subsequently spun out to form Celgene, one of the world’s largest biotechnology companies.BioNJ’s Annual Meeting brings together executives of biotechnology and pharmaceutical companies, professional service providers, government officials, academic leaders and others for an evening of networking, business discussions and award presentations.BioNJ is The Gateway to Health, a powerful network of 400 Member Investors representing research-based life sciences companies and other contributors to a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount. Because Patients Can’t Wait, BioNJ is dedicated to propelling this rich, innovation hub forward in New Jersey and beyond to help stimulate the discovery, development and commercialization of therapies and cures to save and improve lives and lessen the burden of illness and disease to society. As the industry’s voice in New Jersey, BioNJ fulfills its mission to help companies help patients by driving capital formation and fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education, and offering a cost-saving array of critical commercial resources.John Theurer Cancer Center at Hackensack Meridian Health Hackensack University Medical Center is New Jersey’s largest and most comprehensive center dedicated to the diagnosis, treatment, management, research, screenings, and preventive care as well as survivorship of patients with all types of cancers. The 14 specialized divisions covering the complete spectrum of cancer care have developed a close-knit team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. Each year, more people in the New Jersey/New York metropolitan area turn to John Theurer Cancer Center for cancer care than to any other facility in New Jersey. Housed within Hackensack University Medical Center, a 775-bed not-for-profit teaching, tertiary care, and research hospital, John Theurer Cancer Center provides state-of-the-art technological advances, compassionate care, research innovations, medical expertise, and a full range of aftercare services that distinguish John Theurer Cancer Center from other facilities. For additional information, please visit
Additionally, the network has more than 160 patient care locations throughout the state which include ambulatory care centers, surgery centers, home health services, long-term care and assisted living communities, ambulance services, lifesaving air medical transportation, fitness and wellness centers, rehabilitation centers, and urgent care and after-hours centers. Hackensack Meridian Health has 33,000 team members, and 6,500 physicians and is a distinguished leader in health care philanthropy, committed to the health and well-being of the communities it serves.
The network's notable distinctions include having one of only five major academic medical centers in the nation to receive Healthgrades America's 50 Best Hospitals Award for five or more consecutive years, four hospitals among the top 10 in New Jersey, including Hackensack University Medical Center which is ranked No. 1 by U.S. News and World Report. Other honors include consistently achieving Magnet® recognition for nursing excellence from the American Nurses Credentialing Center, recipient of the John M. Eisenberg Award for Patient Safety and Quality from The Joint Commission and the National Quality Forum, a six-time recipient of Fortune's "100 Best Companies to Work For," one of the "20 Best Workplaces in Health Care" in the nation, and the number one "Best Place to Work for Women." Hackensack Meridian Health is a member of AllSpire Health Partners, an interstate consortium of leading health systems, to focus on the sharing of best practices in clinical care and achieving efficiencies.
For additional information, please visit




































